- Home
- EXEL vs MMYT Comparison
EXEL vs MMYT Comparison
Compare EXEL & MMYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- MMYT
- Stock Information
- Founded
- EXEL 1994
- MMYT 2000
- Country
- EXEL United States
- MMYT India
- Employees
- EXEL 1147
- MMYT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- MMYT Transportation Services
- Sector
- EXEL Health Care
- MMYT Consumer Discretionary
- Exchange
- EXEL Nasdaq
- MMYT Nasdaq
- Market Cap
- EXEL 11.3B
- MMYT 11.3B
- IPO Year
- EXEL 2000
- MMYT 2010
- Fundamental
- Price
- EXEL $40.37
- MMYT $92.29
- Analyst Decision
- EXEL Buy
- MMYT Strong Buy
- Analyst Count
- EXEL 18
- MMYT 2
- Target Price
- EXEL $39.59
- MMYT $127.50
- AVG Volume (30 Days)
- EXEL 2.6M
- MMYT 1.5M
- Earning Date
- EXEL 08-05-2025
- MMYT 07-22-2025
- Dividend Yield
- EXEL N/A
- MMYT N/A
- EPS Growth
- EXEL 237.58
- MMYT N/A
- EPS
- EXEL 2.20
- MMYT 0.83
- Revenue
- EXEL $2,298,922,000.00
- MMYT $978,336,000.00
- Revenue This Year
- EXEL $9.37
- MMYT $25.01
- Revenue Next Year
- EXEL $11.05
- MMYT $21.01
- P/E Ratio
- EXEL $18.12
- MMYT $113.77
- Revenue Growth
- EXEL 24.49
- MMYT 25.02
- 52 Week Low
- EXEL $21.36
- MMYT $76.95
- 52 Week High
- EXEL $48.85
- MMYT $123.00
- Technical
- Relative Strength Index (RSI)
- EXEL 42.39
- MMYT 41.91
- Support Level
- EXEL $41.03
- MMYT $87.71
- Resistance Level
- EXEL $42.07
- MMYT $102.00
- Average True Range (ATR)
- EXEL 0.95
- MMYT 3.33
- MACD
- EXEL -0.42
- MMYT -0.64
- Stochastic Oscillator
- EXEL 12.85
- MMYT 48.19
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.